MiniTool Released MovieMaker 8.0 with Multi-Track Video Editing Features
VANCOUVER, BC, Dec. 11, 2024 /PRNewswire/ -- MiniTool Software Limited has released the latest version of its video editing tool, MiniTool MovieMaker 8.0. The completely new edition rebuilds its timeline by supporting multi-track editing to optimize...
Live from ASH 2024 | Oral Report Features Encouraging Data of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in R/R MM, Including a Median PFS Over 9 Months
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
Live from ASH 2024 | Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax in Combinations Demonstrates Potential Clinical Benefit in Patients with Prior Exposure to Venetoclax
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
The new battleground for commercial card providers: Rewards and flexibility, Ascenda report reveals
Fintech disruption and evolving rewards reshape business spending landscape NEW YORK, Dec. 10, 2024 /PRNewswire/ -- Ascenda, the global leader in loyalty as a service, today released its 2024 State of Loyalty: Commercial Cards report. The report...
Live from ASH 2024 | First Dataset of Olverembatinib as Second-Line Therapy in Patients with Non-T315I-Mutant CP-CML Presented in Oral Report
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
Live from ASH 2024 | 1.5-Year Follow-Up Data from a Global Study of Olverembatinib Reaffirms Potential in Overcoming Resistance/Intolerance to Ponatinib or Asciminib
ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing, and commercializing therapies to address global unmet medical needs primarily for...
QS World University Rankings: Sustainability 2025
LONDON, Dec. 10, 2024 /PRNewswire/ -- QS Quacquarelli Symonds, global higher education experts, released the third edition of the QS World University Rankings: Sustainability, showcasing over 1,740 universities from 107 locations. The University of...
Mastercard Economics Institute: APAC growth expected to hold steady in 2025; global policy resets may see shift in gears
Most APAC economies to see slight pickup in GDP growth Uptick expected in consumer discretionary spend, focusing on travel, big-ticket purchases and experiences SINGAPORE, Dec. 10, 2024 /PRNewswire/ -- The Mastercard Economics Institute (MEI) has...
Abu Dhabi Finance Week 2024 Opens with Top Financial Leaders in the 'Capital of Capital'
ABU DHABI, UAE, Dec. 10, 2024 /PRNewswire/ -- Under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, the Crown Prince of Abu Dhabi and Chairman of the Executive Council, one of MENA's most anticipated four-day event...
EpiVax Drives Immunogenicity Innovation in 2024: Year in Review
PROVIDENCE, R.I., Dec. 7, 2024 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity risk assessment for biologic and peptide therapeutics, celebrates a productive 2024 marked by scientific innovation, service diversification, and...